Articles |
the Departments of Physiology (Y.N., H.L.), Surgery (D.K.R., N.C.C., R.E.M., M.C.O.), and Medicine (D.J.P.), Columbia University College of Physicians and Surgeons, New York, NY.
Correspondence to David J. Pinsky, MD, Columbia University, College of Physicians and Surgeons, Department of Medicine, PH 10-Stem, 630 W 168th St, New York, NY 10032. E-mail djp5@columbia.edu.
Prostaglandin E1 (PGE1) is often added to the donor pulmonary flush solution to enhance clinical lung preservation for transplantation. Although PGE1 is thought to act as a pulmonary vasodilator during the harvest period, the precise mechanism(s) of action whereby PGE1 enhances lung preservation is unknown. Because cAMP levels decline in endothelial and vascular smooth muscle cells exposed to hypoxia, we hypothesized that a PGE1-mediated increase in cAMP levels within the preserved lungs might improve pulmonary vascular homeostasis following lung transplantation. Rat lungs demonstrated a time-dependent decline in cAMP levels during hypothermic storage, with cAMP levels significantly increased by PGE1 supplementation (
2-fold by 6 hours, P<.0005). To test whether augmenting cAMP levels may enhance lung preservation, experiments were performed using an orthotopic rat left lung transplant model. Compared with controls, supplementing the preservation solution with the membrane-permeable cAMP analogue dibutyryl-cAMP resulted in dose-dependent preservation enhancement, marked by reduced pulmonary vascular resistance (6.0-fold, P<.01), improved arterial oxygenation (3.0-fold, P<.01), reduced graft neutrophil infiltration (1.5-fold, P<.05), and improved recipient survival (7.0-fold, P<.005). Similar preservation enhancement was observed with another cAMP analogue (8-bromo-cAMP) or the phosphodiesterase inhibitor indolidan. Stimulating the cAMP second messenger system by PGE1 supplementation resulted in marked hemodynamic benefits and improved recipient survival, in parallel with reduced graft neutrophil infiltration, vascular permeability, and platelet deposition. These beneficial effects of PGE1 were abrogated by simultaneous administration of the cAMP-dependent protein kinase antagonist Rp-cAMPS. Although an arterial vasodilator (minoxidil) resulted in significant pulmonary vasodilation during harvest, it lacked other nonvasodilating effects of PGE1 and resulted in poor preservation. These data show that harvest vasodilation by itself is insufficient to enhance lung preservation and that PGE1 enhances lung preservation by stimulating the cAMP-dependent protein kinase and promoting nonvasodilatory mechanisms of pulmonary protection.
Key Words: cAMP prostaglandin E1 lung transplantation protein kinase A blood vessels
This article has been cited by other articles:
![]() |
J. Cheng and J. P. Grande Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease Experimental Biology and Medicine, January 1, 2007; 232(1): 38 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Wilkes, T. M. Egan, and H. Y. Reynolds Lung Transplantation: Opportunities for Research and Clinical Advancement Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gohrbandt, S. P. Sommer, S. Fischer, J. M. Hohlfeld, G. Warnecke, A. Haverich, and M. Strueber Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 80 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakaguchi, T. Asai, D. Belov, M. Okada, D. J. Pinsky, A. M. Schmidt, and Y. Naka Influence of ischemic injury on vein graft remodeling: Role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tierney, R. Foster, and D. Ogella A perfusionist's role in lung transplant preservation Perfusion, December 1, 2004; 19(6): 351 - 357. [Abstract] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Minamoto, D. J. Pinsky, T. Fujita, and Y. Naka Timing of Nitric Oxide Donor Supplementation Determines Endothelin-1 Regulation and Quality of Lung Preservation for Transplantation Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 14 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sunose, I. Takeyoshi, H. Tsutsumi, S. Ohwada, N. Oriuchi, K. Matsumoto, and Y. Morishita Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model Ann. Thorac. Surg., October 1, 2001; 72(4): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schutte, A. Lockinger, W. Seeger, and F. Grimminger Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion Eur. Respir. J., July 1, 2001; 18(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. FEATHERSTONE, D. J. CHAMBERS, and F. J. KELLY Comparison of Phosphodiesterase Inhibitors of Differing Isoenzyme Selectivity Added to St. Thomas' Hospital Cardioplegic Solution Used for Hypothermic Preservation of Rat Lungs Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 850 - 856. [Abstract] [Full Text] |
||||
![]() |
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy Circ. Res., May 12, 2000; 86(9): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pinsky and Y. Naka Ann. Thorac. Surg., March 1, 2000; 69(3): 891 - 892. [Full Text] [PDF] |
||||
![]() |
K. Toda, K. Kayano, A. Karimova, Y. Naka, T. Fujita, K. Minamoto, C. Y. Wang, and D. J. Pinsky Antisense Intercellular Adhesion Molecule-1 (ICAM-1) Oligodeoxyribonucleotide Delivered During Organ Preservation Inhibits Posttransplant ICAM-1 Expression and Reduces Primary Lung Isograft Failure Circ. Res., February 4, 2000; 86(2): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kayano, K. Toda, Y. Naka, and D. J. Pinsky Identification of Optimal Conditions for Lung Graft Storage With Euro-Collins Solution by Use of a Rat Orthotopic Lung Transplant Model Circulation, November 9, 1999; 100(90002): II-257 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hillinger, R. A. Schmid, P. Sandera, U. Stammberger, D. Schneiter, G. Schoedon, and W. Weder 8-Br-cGMP is superior to prostaglandin e1 for lung preservation Ann. Thorac. Surg., October 1, 1999; 68(4): 1138 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. CHIANG, K. WU, C.-P. YU, H.-C. YAN, W.-C. PERNG, and C.-P. WU Hypothermia and Prostaglandin E1 Produce Synergistic Attenuation of Ischemia-Reperfusion Lung Injury Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1319 - 1323. [Abstract] [Full Text] |
||||
![]() |
K. Kayano, K. Toda, Y. Naka, K. Okada, M. C. Oz, and D. J. Pinsky SUPERIOR PROTECTION IN ORTHOTOPIC RAT LUNG TRANSPLANTATION WITHCYCLIC ADENOSINE MONOPHOSPHATE AND NITROGLYCERIN-CONTAINING PRESERVATIONSOLUTION J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 135 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Pearse, E. M. Wagner, and S. Permutt Effect of ventilation on vascular permeability and cyclic nucleotide concentrations in ischemic sheep lungs J Appl Physiol, January 1, 1999; 86(1): 123 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pinsky Invited Commentary Ann. Thorac. Surg., December 1, 1996; 62(6): 1586 - 1587. [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |